Maryland Statutes

§ 2-802

Maryland·Article ghg Health - General·Title 2
(a)A manufacturer or wholesale distributor may not engage in price gouging in the sale of an essential off–patent or generic drug.
(b)It is not a violation of subsection (a) of this section for a wholesale distributor to increase the price of an essential off–patent or generic drug if the price increase is directly attributable to additional costs for the drug imposed on the wholesale distributor by the manufacturer of the drug.

Free access — add to your briefcase to read the full text and ask questions with AI

Maryland § 2-802 — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Nearby Sections

15
§ 2-1001
§ 2-1001
§ 2-1002
§ 2-1002
§ 2-1003
§ 2-1003
§ 2-1004
§ 2-1004
§ 2-101
§ 2-101
§ 2-102
§ 2-102
§ 2-103
§ 2-103
§ 2-104
§ 2-104
§ 2-105
§ 2-105
§ 2-106
§ 2-106
§ 2-107
§ 2-107
§ 2-108
§ 2-108
§ 2-301
§ 2-301
§ 2-302
§ 2-302
§ 2-303
§ 2-303
View on official source ↗